
Chemoimmunotherapy Enhanced Survival vs Chemo Alone in ES-SCLC
Chemotherapy in combination with immunotherapy led to prolonged survival outcomes without increasing the frequency of treatment-related adverse events (TRAEs) vs chemotherapy alone in patients with extensive-stage small cell lung cancer (ES-SCLC), …